IntroductionThe study investigation examined the immune response to the Janssen Ad26. COV2. S COVID-19 vaccine within a Ugandan cohort. specifically targeting antibodies directed against spike (S) and nucleocapsid (N) proteins. https://www.foldlyers.shop/product-category/fme-f-type-n-type/